|
Piramal Pharma Ltd.
|
QUARTERLY RESULTS
|
|
|
You can view the
Quaterly Results
for the last 5 years.
|
Market Cap. (Rs.)
|
26896.01 Cr.
|
P/BV
|
3.40
|
Book Value (Rs.)
|
59.53
|
|
52 Week High/Low (Rs.)
|
308/182
|
FV/ML
|
10/1
|
P/E(X)
|
295.39
|
|
Bookclosure
|
16/07/2025
|
EPS (Rs.)
|
0.69
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 1933.71 | 2754.07 | 2204.22 | 2241.75 | 1951.14 |
| Total Income From Operations | 1933.71 | 2754.07 | 2204.22 | 2241.75 | 1951.14 |
| | | | | | |
| EXPENDITURE | | | | | |
| Consumption of Raw Materials | 524.35 | 203.68 | 805.44 | 575.14 | 471.48 |
| Purchase of Traded Goods | 342.83 | 546.72 | 161.06 | 394.77 | 314.77 |
| Increase/Decrease in Stocks | -173.13 | 204.58 | -160.67 | -173.44 | -111.88 |
| Employees Cost | 618.59 | 612.01 | 556.24 | 559.53 | 579.69 |
| Depreciation | 197.28 | 242.76 | 196.81 | 192.22 | 184.55 |
| Other Expenses | 514.37 | 626.09 | 504.41 | 544.14 | 492.59 |
| Total Expenses | 2024.29 | 2435.84 | 2063.29 | 2092.36 | 1931.20 |
| | | | | | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | -90.58 | 318.23 | 140.93 | 149.39 | 19.94 |
| Other Income | 58.40 | 42.03 | 12.13 | 61.11 | 19.54 |
| P/L Before Interest, Excpt. Items & Tax | -32.18 | 360.26 | 153.06 | 210.50 | 39.48 |
| Interest | 86.15 | 103.68 | 103.31 | 107.64 | 106.96 |
| P/L Before Exceptional Items & Tax | -118.33 | 256.58 | 49.75 | 102.86 | -67.48 |
| Exceptional Items | 20.74 | 0.00 | 0.00 | 0.00 | 0.00 |
| P/L Before Tax | -97.59 | 256.58 | 49.75 | 102.86 | -67.48 |
| Tax | 2.68 | 119.30 | 63.12 | 97.53 | 43.56 |
| P/L After Tax from Ordinary Activities | -100.27 | 137.28 | -13.37 | 5.33 | -111.04 |
| Net Profit/Loss For the Period | -100.27 | 137.28 | -13.37 | 5.33 | -111.04 |
| Share Of P/L Of Associates | 18.57 | 16.22 | 17.05 | 17.26 | 22.40 |
| Net P/L After Minority Interest & Share Of Associates | -81.70 | 153.50 | 3.68 | 22.59 | -88.64 |
| | | | | | |
| Equity Share Capital | 1324.82 | 1324.34 | 1323.58 | 1323.14 | 1322.95 |
| EPS Before Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -0.62 | 1.16 | 0.03 | 0.17 | -0.67 |
| Diluted EPS (Rs.) | -0.62 | 1.16 | 0.03 | 0.17 | -0.67 |
| EPS After Extra Ordinary * | | | | | |
| Basic EPS (Rs.) | -0.62 | 1.16 | 0.03 | 0.17 | -0.67 |
| Diluted EPS (Rs.) | -0.62 | 1.16 | 0.03 | 0.17 | -0.67 |
| | | | | | |
| PBITOE Margin (%) | -4.68 | 11.55 | 6.39 | 6.66 | 1.02 |
| PBTE Margin (%) | -6.11 | 9.31 | 2.25 | 4.58 | -3.45 |
| PBT Margin (%) | -5.04 | 9.31 | 2.25 | 4.58 | -3.45 |
| PAT Margin (%) | -5.18 | 4.98 | -0.60 | 0.23 | -5.69 |
| PAT After MI And SOA Margin (%) | -4.22 | 5.57 | 0.16 | 1.00 | -4.54 |
